These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26858129)

  • 1. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Sun Y; Yu W; Sturgis EM; Peng W; Lei D; Wei Q; Song X; Li G
    BMC Cancer; 2016 Feb; 16():70. PubMed ID: 26858129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Lei D; Sturgis EM; Wang LE; Liu Z; Zafereo ME; Wei Q; Li G
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1484-91. PubMed ID: 20501759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Jin L; Sturgis EM; Zhang Y; Huang Z; Wei P; Guo W; Wang Z; Wei Q; Song X; Li G
    Carcinogenesis; 2013 Jul; 34(7):1551-7. PubMed ID: 23508638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Wang Z; Sturgis EM; Zhang F; Lei D; Liu Z; Xu L; Song X; Wei Q; Li G
    Mol Cancer; 2012 Mar; 11():17. PubMed ID: 22449259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Zhang Y; Sturgis EM; Zafereo ME; Wei Q; Li G
    Cancer; 2011 Mar; 117(6):1227-35. PubMed ID: 21381012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Wang LE; Sturgis EM; El-Naggar AK; Hong WK; Amos CI; Spitz MR; Wei Q
    Clin Cancer Res; 2006 Sep; 12(18):5596-602. PubMed ID: 17000697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Lei D; Sturgis EM; Liu Z; Zafereo ME; Wei Q; Li G
    Carcinogenesis; 2010 Feb; 31(2):222-7. PubMed ID: 19955391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck.
    Zafereo ME; Sturgis EM; Aleem S; Chaung K; Wei Q; Li G
    Cancer Prev Res (Phila); 2009 May; 2(5):432-9. PubMed ID: 19401526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.
    Li F; Sturgis EM; Zafereo ME; Liu Z; Wang LE; Wei Q; Li G
    Int J Cancer; 2009 Dec; 125(11):2660-5. PubMed ID: 19585505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
    Zhang Y; Sturgis EM; Huang Z; Zafereo ME; Wei Q; Li G
    Cancer; 2012 Jan; 118(2):485-92. PubMed ID: 21717430
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Costa EFD; Lima TRP; Lopes-Aguiar L; Nogueira GAS; Visacri MB; Quintanilha JCF; Pincinato EC; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
    Tumour Biol; 2020 Jul; 42(7):1010428320938494. PubMed ID: 32628088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    Li F; Sturgis EM; Chen X; Zafereo ME; Wei Q; Li G
    Cancer; 2010 May; 116(10):2350-9. PubMed ID: 20225330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.
    Guan X; Liu Z; Liu H; Yu H; Wang LE; Sturgis EM; Li G; Wei Q
    FASEB J; 2013 Apr; 27(4):1404-12. PubMed ID: 23271051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
    Wang J; Gao J; Li Y; Zhao X; Gao W; Peng L; Yan D; Liu L; Li D; Wei L; Qi J; Zhou C
    Gene; 2013 Jul; 524(2):193-6. PubMed ID: 23618817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
    Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
    Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
    Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
    Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Zafereo ME; Sturgis EM; Liu Z; Wang LE; Wei Q; Li G
    Carcinogenesis; 2009 Jun; 30(6):997-1002. PubMed ID: 19369580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.